![Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma | Journal of Medicinal Chemistry Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b01290/asset/images/large/jm-2017-01290b_0018.jpeg)
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma | Journal of Medicinal Chemistry
![Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a | Journal of Medicinal Chemistry Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm901543m/asset/images/large/jm-2009-01543m_0007.jpeg)
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a | Journal of Medicinal Chemistry
![Current Treatment Strategies and Risk Stratification for Oral Carcinoma | American Society of Clinical Oncology Educational Book Current Treatment Strategies and Risk Stratification for Oral Carcinoma | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2023/edbk.2023.43/edbk_389810/20230516/images/large/edbk_389810t2.jpeg)
Current Treatment Strategies and Risk Stratification for Oral Carcinoma | American Society of Clinical Oncology Educational Book
![Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist | Journal of Medicinal Chemistry Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00424/asset/images/large/jm0c00424_0011.jpeg)
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist | Journal of Medicinal Chemistry
![Metabolites | Free Full-Text | Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature Metabolites | Free Full-Text | Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature](https://pub.mdpi-res.com/metabolites/metabolites-13-00919/article_deploy/html/images/metabolites-13-00919-g001-550.jpg?1691220417)